BioSpace News Archive

Job Trends

Lipocine Announces Completion of Enrollment in LPCN 1144 Liver Imaging Study in Subjects At-Risk for NASH

Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company, today announced the completion of enrollment in the proof-of-concept clinical study with LPCN 1144 to assess liver fat changes in hypogonadal men at risk of developing non-alcoholic steatohepatitis

November 5, 2018
·
5 min read
Maverick Medical AI Raises $700,000

- Maverick Medical AI has announced that it has raised $700,000 from The Time, the leading Israeli technology incubator in the field of Artificial Intelligence, together with the Israel Innovation Authority.

November 5, 2018
·
2 min read
Business

Veristat Partners with TRI to Provide Centralized and Risk-Based Monitoring Technology to Their Biopharmaceutical Clients

Veristat announced today that it has partnered with Triumph Research Intelligence (TRI), a global leader providing technology and solutions for centralized and risk-based monitoring (RBM) to improve clinical trial quality and compliance.

November 5, 2018
·
3 min read
Biotech Bay

SEVENTH ANNUAL BREAKTHROUGH PRIZE -- “THE OSCARS OF SCIENCE” -- CELEBRATES TOP ACHIEVEMENTS IN PHYSICS, LIFE SCIENCES & MATHEMATICS; AWARDS $22 MILLION IN PRIZES AT GALA TELEVISED CEREMONY IN SILICON VALLEY

Special Tribute to Stephen Hawking Echoes Evening’s Theme: “Look Up!”

November 5, 2018
·
13 min read
Policy

EMA Validates and Grants Accelerated Assessment of Marketing Authorization Application for Daiichi Sankyo’s FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML

Application based on results of pivotal phase 3 QuANTUM-R study of quizartinib in patients with relapsed/refractory FLT3-ITD AML

November 5, 2018
·
6 min read
Business

Valens Signs Multi-Year Cannabis Extraction Agreement with GTEC Holdings

Valens GroWorks Corp. is pleased to announce that it has entered into a multi-year cannabis extraction services agreement (the “Agreement”) with GTEC Holdings

November 5, 2018
·
4 min read
Aerogen Accelerates Global Growth with Temasek Investment

Aerogen today announced that Temasek, a global investment company headquartered in Singapore, has acquired a minority stake in Aerogen through the purchase of a secondary share interest. Financial terms of the transaction were not disclosed.

November 5, 2018
·
2 min read
Genetown

Insulet Raises Awareness for National Diabetes Awareness Month

Highlights Include Beyond Type Run Team NYC Marathon Sponsorship, NASDAQ Closing Bell Ceremony and Global Fundraising Events

November 5, 2018
·
5 min read
Policy

Vizient, Inc. Disappointed as CMS Finalizes 340B & “Site-Neutral” Policies in Final OPPS Rule

Vizient, Inc. is disappointed that the Centers for Medicare and Medicaid Services (CMS) opted to finalize site-neutral payment reductions and the expansion of payment cuts related to the 340B Drug Pricing Program in the final 2019 Outpatient Prospective Payment System (OPPS) rule.

November 5, 2018
·
2 min read
FDA

Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology

Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System.

November 5, 2018
·
2 min read